Robert Augustin
AeroLeads people directory · profile

Robert Augustin Email & Phone Number

Director Strategic Partnering Cardiorenalmetabolism at Boehringer Ingelheim
Location: Biberach an Der Riß, Baden-württemberg, Germany 12 work roles 3 schools
1 work email found @boehringer-ingelheim.com LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email r****@boehringer-ingelheim.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Director Strategic Partnering Cardiorenalmetabolism
Location
Biberach an Der Riß, Baden-württemberg, Germany
Company size

Who is Robert Augustin? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Robert Augustin is listed as Director Strategic Partnering Cardiorenalmetabolism at Boehringer Ingelheim, a with 45532 employees, based in Biberach an Der Riß, Baden-württemberg, Germany. AeroLeads shows a work email signal at boehringer-ingelheim.com and a matched LinkedIn profile for Robert Augustin.

Robert Augustin previously worked as Director Strategic Partnering Cardiometabolism at Boehringer Ingelheim and Associate Director Strategic Partnering CardioMetabolism at Boehringer Ingelheim. Robert Augustin holds Doctor Of Philosophy (Phd); Department Of Anatomy And Cell Biology, Faculty Of Medicine from The Martin Luther University Of Halle-Wittenberg.

Company email context

Email format at Boehringer Ingelheim

This section adds company-level context without repeating Robert Augustin's masked contact details.

{first}.{last}@boehringer-ingelheim.com
89% confidence

AeroLeads found 1 current-domain work email signal for Robert Augustin. Compare company email patterns before reaching out.

Profile bio

About Robert Augustin

Drug discovery professional with a track record to deliver clinical stage assets - e.g. the GCGR/GLP-1R dual agonist Survodutide, the NPY2R agonist BI 1820237, and a novel first-in class triple agonist BI 3034701. 15 years of international experience in cardiometabolic research in academia and industry leading people, teams, projects, and collaborations. In-depth knowledge of unmet medical needs in cardiometabolic indications and experienced in small molecule, peptide, and antibody based drug discovery from target identification up to early clinical development.

Listed skills include Pharmaceutical Industry, Drug Discovery, Research Projects, Type 2 Diabetes, and 18 others.

Current workplace

Robert Augustin's current company

Company context helps verify the profile and gives searchers a useful next step.

Boehringer Ingelheim
Boehringer Ingelheim
Director Strategic Partnering Cardiorenalmetabolism
Biberach, BW, DE
Employees
45532
AeroLeads page
12 roles

Robert Augustin work experience

A career timeline built from the work history available for this profile.

Director Strategic Partnering Cardiometabolism

Ingelheim Am Rhein, Rhineland-Palatinate, De

Associate Director Strategic Partnering Cardiometabolism

Ingelheim Am Rhein, Rhineland-Palatinate, De

Jan 2023 - Jul 2024

Associate Director R&D Project Management And Development Strategies

Ingelheim Am Rhein, Rhineland-Palatinate, De

- R&D project leader for NASH siRNA program

Oct 2021 - Dec 2022

International Project Leader

Ingelheim Am Rhein, Rhineland-Palatinate, De

- International Project Leader TA Cardiometabolism for two programs leading them to achieve Start of Development

Sep 2020 - Oct 2021

Senior Principal Scientist

Ingelheim Am Rhein, Rhineland-Palatinate, De

Research Project Leader in research collaboration with Gubra on Novel PolyAgonists for Obesity

May 2019 - Sep 2020

Principal Scientist

Ingelheim Am Rhein, Rhineland-Palatinate, De

Research project leader in a research collaboration with Gubra to develop next generation obesity treatments (Link) delivering a clinical candidate

Sep 2017 - Apr 2019

Principal Scientist, Scientific Expert

Bagsværd, Dk

- Research project lead for an early incretin portfolio project - Applying molecular pharmacology investigating GPCR signaling bias and receptor kinetics- Support hypothesis generating activities for differentiation of marketed and clinically investigated incretin therapies by pre-clinical mode of action studies- Driving the concept of biomarker strategies for target engagement and physiological response markers to support PK/PD understanding to facilitate decision making in projects - Heading an in vitro pharmacology laboratory supervising technical staff and a Master student

Nov 2015 - Aug 2017

Translational Medicine And Biomarker Expert

Ingelheim Am Rhein, Rhineland-Palatinate, De

- Responsibility for biomarker strategies as integral part of early clinical development plans within the therapeutic area of cardiometabolic diseases (indications type 2 diabetes, obesity, and NASH/NAFLD)- Translational Medicine and Biomarker Expert for the VAP-1 inhibitor program in NASH/NAFLD (Pharmaxis VAP-1 inhibitor BI 1467335/PXS-4728A http://www.pharmaxis.com.au/product-pipeline/amine-oxidase-platform/ssao-inhibitor-pxs4728a/)- Translational Medicine and Biomarker Expert for the GLP-1R/GCGR agonist program - Responsible for leading translational research activities including external collaborations (e.g. Mainz Gutenberg Heart study; IMI 2-NASH call)- Biomarker representative acting at the interface between research and development to facilitate transition of projects towards early clinical development including co-ordination of fit-for purpose biomarker assay development and pharmacogenomics strategies

May 2015 - Oct 2015

Principal Scientist

Ingelheim Am Rhein, Rhineland-Palatinate, De

- Project leader in projects from early discovery up to start of pre-clinical development- Project leader in research collaboration Zealand Pharma on GLP-1R/GCGR agonist, delivery of pre-clinical development candidate (https://www.zealandpharma.com/glp1glucagon-dualacting-agonist/)- Lead the process for selecting a 2nd target for continued collaboration with Zealand Pharma leading to long-acting amyling program now in Ph1(https://www.zealandpharma.com/longacting-amylin-analog/) - Leading projects in indications of type 2 diabetes, obesity, and atherosclerosis (dyslipidemia) comprising modalities of small molecules, peptides, and antibodies- Reviewing in-licensing opportunities- Support clinical programs by advancing scientific knowledge and expertise by pre-clinical studies - Established in vitro pancreatic islet lab to support projects in phases of target discovery (e.g. GPR142) , lead-optimization, and clinical compounds - Leading target identification, validation, and biomarker discovery activities- Head of an in vitro pharmacology laboratory supervising technicians and a postdoctoral fellow

Feb 2007 - Apr 2015

Post-Doctoral Fellowship/Junior Research Group Leader

Nuthetal, De

- From 06/2006 Junior Research Group LeaderIndependent project researcher with supervising responsibilities for technical staff and students- Until 06/2006 Postdoctoral-Fellow⋅Generation & phenotypic characterization of knockout mice with focus on metabolic phenotypes ⋅Leading a target discovery and validation project in an academia-industry (Develogen)collaboration (Federal Ministry of Education and Research grant) in the area of type 2 diabetes/obesity⋅Supervising PhD students

Dec 2004 - Feb 2007
Team & coworkers

Colleagues at Boehringer Ingelheim

Other employees you can reach at boehringer-ingelheim.com. View company contacts for 45532 employees →

3 education records

Robert Augustin education

Doctor Of Philosophy (Phd); Department Of Anatomy And Cell Biology, Faculty Of Medicine

The Martin Luther University Of Halle-Wittenberg

Education record

Università Degli Studi Di Milano

Diploma, Biochemistry

The Martin Luther University Of Halle-Wittenberg
FAQ

Frequently asked questions about Robert Augustin

Quick answers generated from the profile data available on this page.

What company does Robert Augustin work for?

Robert Augustin works for Boehringer Ingelheim.

What is Robert Augustin's role at Boehringer Ingelheim?

Robert Augustin is listed as Director Strategic Partnering Cardiorenalmetabolism at Boehringer Ingelheim.

What is Robert Augustin's email address?

AeroLeads has found 1 work email signal at @boehringer-ingelheim.com for Robert Augustin at Boehringer Ingelheim.

Where is Robert Augustin based?

Robert Augustin is based in Biberach an Der Riß, Baden-württemberg, Germany while working with Boehringer Ingelheim.

What companies has Robert Augustin worked for?

Robert Augustin has worked for Boehringer Ingelheim, Novo Nordisk, German Institute Of Human Nutrition Potsdam-Rehbruecke; Department Of Pharmacology, and Washington University In St. Louis; Department Of Obstetrics And Gynecology.

Who are Robert Augustin's colleagues at Boehringer Ingelheim?

Robert Augustin's colleagues at Boehringer Ingelheim include Maria Aursulesei, Dzenita Mustafic-Karahodzic, Joel Parungao, Carlo Piselli, and Claudia Diaz Gutierrez.

How can I contact Robert Augustin?

You can use AeroLeads to view verified contact signals for Robert Augustin at Boehringer Ingelheim, including work email, phone, and LinkedIn data when available.

What schools did Robert Augustin attend?

Robert Augustin holds Doctor Of Philosophy (Phd); Department Of Anatomy And Cell Biology, Faculty Of Medicine from The Martin Luther University Of Halle-Wittenberg.

What skills is Robert Augustin known for?

Robert Augustin is listed with skills including Pharmaceutical Industry, Drug Discovery, Research Projects, Type 2 Diabetes, Obesity, Cardiovascular Disease, Pharmacology, and Biochemistry.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.